Ortho Clinical Diagnostics Holdings PLC
NASDAQ:OCDX
Ortho Clinical Diagnostics Holdings PLC
Research & Development
Ortho Clinical Diagnostics Holdings PLC
Research & Development Peer Comparison
Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors
Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Ortho Clinical Diagnostics Holdings PLC
NASDAQ:OCDX
|
Research & Development
-$126.2m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
Becton Dickinson and Co
NYSE:BDX
|
Research & Development
-$1.2B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-9%
|
|
Boston Scientific Corp
NYSE:BSX
|
Research & Development
-$1.4B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-5%
|
|
Stryker Corp
NYSE:SYK
|
Research & Development
-$1.3B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-9%
|
|
Abbott Laboratories
NYSE:ABT
|
Research & Development
-$2.6B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-7%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Research & Development
-$1B
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
-20%
|
See Also
What is Ortho Clinical Diagnostics Holdings PLC's Research & Development?
Research & Development
-126.2m
USD
Based on the financial report for Jan 2, 2022, Ortho Clinical Diagnostics Holdings PLC's Research & Development amounts to -126.2m USD.
What is Ortho Clinical Diagnostics Holdings PLC's Research & Development growth rate?
Research & Development CAGR 5Y
-5%
Over the last year, the Research & Development growth was -12%. The average annual Research & Development growth rates for Ortho Clinical Diagnostics Holdings PLC have been -9% over the past three years , -5% over the past five years .